Antigen, in the presence of TGF-β, induces up-regulation of FoxP3 gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2105-2114

  Kapp, Judith A ^a,b,c   Honjo, Kazuhito ^b   Kapp, Linda M ^a   Goldsmith, Kelly ^b   Bucy, R Pat ^b  

^a UNIVERSITY OF ALABAMA   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; ANTIBODY; CD3 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; UPREGULATION; ANIMAL; CLONAL ANERGY; DRUG EFFECT; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CLONAL ANERGY; FORKHEAD TRANSCRIPTION FACTORS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; INTERFERON TYPE II; MICE; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 34848864537     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.4.2105     Document Type: Article

References (66)

1. Gershon, R. K., and K. Kondo. 1971. Infectious immunological tolerance. Immunology 21: 903-914.
2. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
3. Taguchi, O., and Y. Nishizuka. 1987. Self tolerance and localized autoimmunity: mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance. J. Exp. Med. 165: 146-156.
4. Sakaguchi, S., T. Takahashi, and Y. Nishizuka. 1982. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156: 1577-1586.
5. Schubert, L. A., E. Jeffery, Y. Zhang, F. Ramsdell, and S. F. Ziegler. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276: 37672-37679.
6. + T regulatory cells. Nat. Immunol. 4: 337-342.
7. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
8. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
9. + regulatory T cells. Nat. Immunol. 4: 330-336.
10. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
11. + regulatory T cells. Int. Immunol. 16: 1643-1656.
12. + regulatory T cells. J. Exp. Med. 201: 1061-1067.
13. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
14. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
15. + regulatory T cells in vivo. J. Exp. Med. 198: 249-258.
16. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886-8891.
17. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
18. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189: 877-882.
19. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164: 183-190.
20. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167: 188-195.
21. + regulatory T cells by oral antigen administration. J. Immunol. 167: 4245-4253.
22. - precursors. J. Immunol. 169: 4183-4189.
23. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
24. - precursors. Am. J. Transplant. 4: 1614-1627.
25. + T cells: a population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 28: 3435-3447.
26. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
27. Zekzer, D., F. S. Wong, L. Wen, M. Altieri, T. Gurlo, H. von Grafenstein, and R. S. Sherwin. 1997. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 46: 1124-1132.
28. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
29. + regulatory T cell activity in both humans and mice. J. Immunol. 172: 834-842.
30. high-induced colitis by a TGF-β-dependent mechanism. J. Immunol. 170: 2516-2522.
31. - regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196: 237-246.
32. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35: 2886-2895.
33. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
34. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
35. + TCR transgenic T cells alone can reject vascularized heart transplants via the indirect pathway of alloantigen recognition. Transplantation 77: 452-455.
36. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
37. Honjo, K., X. Y. Xu, J. A. Kapp, and R. P. Bucy. 2004. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide. Am. J. Transplant 4: 1762-1768.
38. + T cells in major histocompatibility complex class II-deficient mice. Science 253: 1417-1420.
39. 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342: 435-438.
40. Ehst, B. D., E. Ingulli, and M. K. Jenkins. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant 3: 1355-1362.
41. Bucy, R. P. 1986. Alloantigen-specific suppressor T cells are not inhibited by cyclosporin A, but do require IL 2 for activation. J. Immunol. 137: 809-813.
42. Bucy, R. P. 1988. The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro. Immunopharmacology 15: 65-72.
43. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
44. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
45. Sheehy, M. E., A. B. McDermott, S. N. Furlan, P. Klenerman, and D. F. Nixon. 2001. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods 249: 99-110.
46. Ritchie, D. S., I. F. Hermans, J. M. Lumsden, C. B. Scanga, J. M. Roberts, J. Yang, R. A. Kemp, and F. Ronchese. 2000. Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J. Immunol. Methods 246: 109-117.
47. + T cells activated in the presence of TGFβ express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int. Immunol. 18: 1549-1562.
48. H17 lineage. Nature 441: 231-234.
49. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
50. H17 and regulatory T cells. Nature 441: 235-238.
51. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
52. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 99: 8213-8218.
53. + regulatory T cell function in alloimmunity. J. Immunol. 176: 329-334.
54. LaFaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient antimyelin basic protein T cell receptor transgenic mice. Cell 78: 399-408.
55. Zhou, P., R. Borojevic, C. Streutker, D. Snider, H. Liang, and K. Croitoru. 2004. Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens. J. Immunol. 172: 1515-1523.
56. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
57. + regulatory T-cell selection. Immunol. Rev. 212: 74-85.
58. + regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc. Natl. Acad. Sci. USA 103: 8453-8458.
59. + regulatory T cells. J. Immunol. 171: 5678-5682.
60. Holan, V., and N. A. Mitchison. 1983. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens. Eur. J. Immunol. 13: 652-657.
61. Wise, M. P., F. Bemelman, S. P. Cobbold, and H. Waldmann. 1998. Linked suppression of skin graft rejection can operate through indirect recognition. J. Immunol. 161: 5813-5816.
62. Davies, J. D., L. Y. Leong, A. Mellor, S. P. Cobbold, and H. Waldmann. 1996. T cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156: 3602-3607.
63. Miller, A., O. Lider, and H. L. Weiner. 1991. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174: 791-798.
64. + T-helper and a T-killer cell. Nature 393: 474-478.
65. + regulatory T cells from nonobese diabetic mice. J. Immunol. 175: 3053-3059.
66. Samy, E. T., Y. Y. Setiady, K. Ohno, P. Pramoonjago, C. Sharp, and K. S. Tung. 2006. The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function. Immunol. Rev. 212: 170-184.